Clinical Epidemiology Unit, Robert Debré Hospital, AP-HP, and INSERM CIC-EC 1426 and INSERM ECEVE 1123, University of Paris, 48 Bd Sérurier, 75 019, Paris, France.
Public Health Department, Hygée Centre, Lucien Neuwirth Cancer Institute, Saint Priest en Jarez, France and Inserm, Clinical Investigation Center 1408, 42055, Saint-Etienne, France.
BMC Cancer. 2023 Jan 6;23(1):21. doi: 10.1186/s12885-022-10169-3.
The objective of this study was to assess the effectiveness of a Patient Navigation Intervention targeting deprived patients for Colo-Rectal Cancer (CRC) screening participation.
A cluster randomized controlled trial was conducted in 5 districts. Peer Lay Patient Navigators were recruited to operate in deprived areas. Eligible participants had to be between 50 and 74 years old, live in these deprived areas and receive an invitation to the nationally organized Colo-Rectal Cancer (CRC) screening during the study period. The theory-driven navigation intervention was deployed for 18 months. A population Health Intervention Research assessment method was used to assess effectiveness and context interaction. The primary criterion was screening participation at 12 months.
Twenty-four thousand two hundred eighty-one individuals were included inside 40 clusters. The increase in participation in the intervention group was estimated at 23%, (ORa = 1.23, CI95% [1.07-1.41], p = 0.003). For the subgroup of individuals who participated, the time delay to participating was reduced by 26% (ORa = 0.74, CI95% [0.57-0.96], p = 0.021). Main factors modulating the effect of the intervention were: closeness of navigator profiles to the targeted population, navigators' abilities to adapt their modus operandi, and facilitating attachment structure.
The ColoNav Intervention succeeded in demonstrating its effectiveness, for CRC screening. Patient Navigation should be disseminate with broader health promotion goals in order to achieve equity in health care.
clinicaltrials.gov NCT02369757 24/02/2015.
本研究旨在评估针对贫困患者的患者导航干预措施对结直肠癌(CRC)筛查参与的有效性。
在 5 个区进行了一项集群随机对照试验。招募了同龄的患者导航员在贫困地区开展工作。符合条件的参与者必须年龄在 50 至 74 岁之间,居住在这些贫困地区,并在研究期间收到参加全国组织的结直肠癌(CRC)筛查的邀请。经过理论驱动的导航干预措施在 18 个月内实施。采用人群健康干预研究评估方法来评估有效性和背景交互作用。主要标准是 12 个月时的筛查参与率。
40 个集群中共有 24281 人入选。干预组的参与率增加了 23%(ORa=1.23,95%CI[1.07-1.41],p=0.003)。对于参与的亚组人群,参与的时间延迟减少了 26%(ORa=0.74,95%CI[0.57-0.96],p=0.021)。调节干预效果的主要因素是:导航员与目标人群的相似程度、导航员适应其工作模式的能力以及促进依附结构。
ColoNav 干预措施成功地证明了其在结直肠癌筛查中的有效性。应该推广患者导航,以实现更广泛的健康促进目标,从而实现医疗保健公平。
clinicaltrials.gov NCT02369757 24/02/2015。